- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Teva nabs experimental Tourette drug in $700M Emalex buyout | ||
| Mi | Chiesi to buy KalVista in $1.9B deal for rare disease drug | ||
| Mi | FDA tests out 'real-time' clinical trials; AbbVie closes in on a KRAS biotech | ||
| Di | Pfizer deals extend patent life for a top-selling rare disease drug | ||
| Di | Boehringer dual-acting obesity shot hits mark in Phase 3 trial | ||
| Di | FDA claims Amgen drug data were 'manipulated'; Erasca slides despite 'home run' results | ||
| Di | Coultreon banks $125M to support testing of former Galapagos immune drug | ||
| Di | Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead. | ||
| Mo | Oruka surges as long-acting psoriasis drug shows early promise | ||
| Mo | Veradermics soars on positive data for baldness treatment | ||
| Mo | Lilly to buy startup Ajax in bid for a better JAK drug | ||
| Mo | Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder | ||
| Fr | Sanofi MS drug rejected in US gets an endorsement in Europe | ||
| Fr | Lilly tumbles on Foundayo's shaky week; FDA to issue vouchers for psychedelics | ||
| 23.04. | FDA approves Regeneron's hearing loss gene therapy | ||
| 23.04. | Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus | ||
| 23.04. | Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs | ||
| 23.04. | Sanofi posts upbeat sales as R&D pressure builds | ||
| 22.04. | Revolution drug shows promise in early pancreatic cancer | ||
| 22.04. | Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial | ||
| 22.04. | Merck adds to pharma's AI push; Roche details MS drug results | ||
| 21.04. | Tortugas debuts with $106M and brain drugs from Hansoh, Eisai | ||
| 21.04. | Merck's fast-ascending kidney cancer drug hits a setback | ||
| 21.04. | BioAge says early data suggest 'best-in-class' potential for inflammation drug | ||
| 21.04. | Trump executive order lifts psychedelics biotechs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.